Development of hyponatremia in non-critical patients receiving total parenteral nutrition: A prospective, multicenter study.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 04 2018
revised: 06 10 2018
accepted: 25 11 2018
pubmed: 14 12 2018
medline: 22 9 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

Hyponatremia is frequent in hospitalized patients, especially in those receiving total parenteral nutrition (TPN). Furthermore, the presence of hyponatremia is associated with increased morbimortality in both groups. The goal of this study is to describe the prevalence of hyponatremia developing during TPN in non-critical patients, and identify risk factors for its appearance. This prospective multicenter study involved 19 Spanish hospitals. Noncritically-ill patients prescribed TPN over a 9-month period were studied. Variables analyzed demographic characteristics, prior comorbidities, drug therapy, PN composition, additional iv fluids, and serum sodium levels. A total of 543 patients were recruited, 60.2% males. Age: 67 (IR 57-76). Of 466/543 who were eunatremic when starting TPN, 18% developed hyponatremia (serum sodium < 135 mmol/L) during TPN. Independent risk factors identified by logistic regression analysis: female (OR 1.74 [95% CI = 1.04-2.92], p = 0.036); severe malnutrition (OR 2.15 [95% CI = 1.16-4.35], p = 0.033); opiates (OR 1.97 [95% CI = 1.10-3.73], p = 0.036); and nausea/vomiting (OR 1.75 [95% CI = 1.04-2.94], p = 0.036). Previously eunatremic patients frequently develop hyponatremia while receiving TPN. In this group, severe malnutrition is an independent risk factor for hyponatremia, as well as previously described risk factors: opiates, nausea/vomiting, and female gender.

Sections du résumé

BACKGROUND & AIMS
Hyponatremia is frequent in hospitalized patients, especially in those receiving total parenteral nutrition (TPN). Furthermore, the presence of hyponatremia is associated with increased morbimortality in both groups. The goal of this study is to describe the prevalence of hyponatremia developing during TPN in non-critical patients, and identify risk factors for its appearance.
METHODS
This prospective multicenter study involved 19 Spanish hospitals. Noncritically-ill patients prescribed TPN over a 9-month period were studied. Variables analyzed demographic characteristics, prior comorbidities, drug therapy, PN composition, additional iv fluids, and serum sodium levels.
RESULTS
A total of 543 patients were recruited, 60.2% males. Age: 67 (IR 57-76). Of 466/543 who were eunatremic when starting TPN, 18% developed hyponatremia (serum sodium < 135 mmol/L) during TPN. Independent risk factors identified by logistic regression analysis: female (OR 1.74 [95% CI = 1.04-2.92], p = 0.036); severe malnutrition (OR 2.15 [95% CI = 1.16-4.35], p = 0.033); opiates (OR 1.97 [95% CI = 1.10-3.73], p = 0.036); and nausea/vomiting (OR 1.75 [95% CI = 1.04-2.94], p = 0.036).
CONCLUSIONS
Previously eunatremic patients frequently develop hyponatremia while receiving TPN. In this group, severe malnutrition is an independent risk factor for hyponatremia, as well as previously described risk factors: opiates, nausea/vomiting, and female gender.

Identifiants

pubmed: 30545660
pii: S0261-5614(18)32547-0
doi: 10.1016/j.clnu.2018.11.014
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2639-2644

Informations de copyright

Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Auteurs

Emilia Gómez-Hoyos (E)

Endocrinology and Nutrition Department, Hospital Clínico Universitario de Valladolid-IEN, Universidad de Valladolid, Valladolid, Spain. Electronic address: emiliagomezhoyos@gmail.com.

Ana Ortolá Buigues (AO)

Endocrinology and Nutrition Department, Hospital Clínico Universitario de Valladolid-IEN, Universidad de Valladolid, Valladolid, Spain.

Maria Dolores Ballesteros Pomar (MD)

Endocrinology and Nutrition Department, Complejo Asistencial Universitario de León, León, Spain.

Alfonso Vidal Casariego (AV)

Endocrinology and Nutrition Department, Complejo Asistencial Universitario de León, León, Spain.

Yaiza García Delgado (YG)

Endocrinology and Nutrition Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.

Maria Julia Ocón Bretón (MJ)

Endocrinology and Nutrition Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

Angel Luis Abad González (AL)

Endocrinology and Nutrition Department, Hospital General Universitario de Alicante, Alicante, Spain.

Luis Miguel Luengo Pérez (LM)

Endocrinology and Nutrition Department, Hospital Infanta Cristina, Badajoz, Spain.

Pilar Matía Martín (PM)

Endocrinology and Nutrition Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IDISSC), Madrid, Spain.

Maria José Tapia Guerrero (MJ)

Endocrinology and Nutrition Department, Hospital Regional Universitario de Málaga, Málaga, Spain.

María Dolores Del Olmo García (MD)

Endocrinology and Nutrition Department, Hospital Universitario Severo Ochoa, Madrid, Spain.

Ana Herrero Ruiz (AH)

Endocrinology and Nutrition Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.

Julia Álvarez Hernández (JÁ)

Endocrinology and Nutrition Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain.

Diego Bellido Guerrero (DB)

Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de Ferrol, Coruña, Spain.

Sandra Herranz Antolín (SH)

Endocrinology and Nutrition Department, Hospital Universitario de Guadarajara, Guadarajara, Spain.

Carmen Tenorio-Jiménez (C)

Endocrinology and Nutrition Department, Complejo Hospitalario de Jaén, Jaén, Spain.

Maria Victoria García Zafra (MV)

Endocrinology and Nutrition Department, Hospital Universitario Santa Lucia, Cartagena, Spain.

Francisco Botella Romero (FB)

Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.

María Argente Pla (MA)

Endocrinology and Nutrition Department, Hospital Universitario y Politécnico de La Fe, Valencia, Spain.

Miguel Angel Martínez Olmos (MA)

Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.

Irene Bretón Lemes (IB)

Endocrinology and Nutrition Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.

Isabelle Runkle De la Vega (IR)

Endocrinology and Nutrition Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IDISSC), Madrid, Spain.

Daniel De Luis Román (D)

Endocrinology and Nutrition Department, Hospital Clínico Universitario de Valladolid-IEN, Universidad de Valladolid, Valladolid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH